PhD Marko Snoj
no.: 12250

researcher – active in research organisation

Research activity

Code	Science	Field	Subfield
3.04.00	Medical sciences	Oncology

Keywords

Oncology, phospholipase A2, metastasizing

Bibliography Representative bibliographic units | Personal| COBISS+

source: COBISS

source: SICRIS

Evaluation (rules)

Evaluation of bibliographic research performance indicators according to ARIS methodology

source: COBISS

source: ARIS

Points

226

A''

30.36

A'

48.46

A1/2

63.48

CI10

3,205

CImax

1,331

h10

16

A1

0.69

A3

1.58

Data for the last 5 years (citations for the last 10 years) on July 26, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)

Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )

Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases

source: WoS

source: Scopus

source: COBISS

Database	Linked records	Citations	Pure citations	Average pure citations
WoS	48	3,877	3,231	67.31
Scopus	52	4,560	3,830	73.65

Mentoring junior researchers

source: ARIS

no.	Name and surname	Type	Period	Code
1	PhD Nebojša Glumac	Uniform doctoral studies	1/1/2003 - 12/31/2008	23342

Doctoral dissertations and other final papers Show

source: COBISS

Employments

source: ARIS

Type of employment	Research org.	Research group
Full time employment (100%, RD:30%)	Institute of Oncology Ljubljana	Department of research

Research projects Legend

source: ARIS

no.	Code	Title	Period	Head	No. of publications
1.	J3-3083	Vascularization and vascular effects as predictive factors for local ablative techniques	2021 - 2024	PhD Gregor Serša	6,846
2.	J3-6796	Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin	2014 - 2017	PhD Maja Čemažar	4,807
3.	J3-4211	Antiangiogenic gene therapy of cancer using electroporation and magnetic nanoparticles as targeted delivery systems	2011 - 2014	PhD Gregor Serša	6,521
4.	J3-4259	Preparation and validation of therapeutic plasmids without selection gene for antibiotic resistance for cancer gene therapy using inducible and tissue-specific promoters	2011 - 2014	PhD Maja Čemažar	5,922
5.	L3-4278	Po odstranitvi varovalne bezgavke: Obsevanje ali kirurgija (Slovene)	2002 - 2005	PhD Marko Snoj	1,834
6.	J3-3501	Creation of tumor vaccines	2002 - 2004	PhD Srdjan Novaković	3,507
7.	J3-3464	Role of tyrosinase RT-PCR in staging of patients with malignant melanoma	2002 - 2004	PhD Marko Hočevar	2,805
8.	L3-2161	Varovalna bezgavka (Slovene)	2000 - 2002	PhD Marko Snoj	1,440
9.	J3-7878	Razvoj avtolognih tumorskih vakcin (Slovene)	2000 - 2001	PhD Srdjan Novaković	5,661
10.	L3-1192	PovejMi: telemedicinska pomoč bolnicam z rakom dojke (Slovene)	1999 - 2001	PhD Ankica Babič	3,791
11.	J3-8744	Phospholipase a2 in tumor tissue	1998 - 1999	PhD Marko Snoj	1,169

ARIS research and infrastructure programmes Legend

source: ARIS

no.	Code	Title	Period	Head	No. of publications
1.	P3-0003	Development and evaluation of new approaches to cancer treatment	2022 - 2024	PhD Gregor Serša	4,006
2.	P3-0003	Development and evaluation of new approaches to cancer treatment	2015 - 2021	PhD Gregor Serša	3,305
3.	P3-0321	Napovedni dejavniki poteka bolezni in odgovora na zdravljenje pri raku dojk in drugih rakih (Slovene)	2009 - 2014	PhD Barbara Jezeršek Novaković	3,838
4.	P3-0321	Prognostic and predictive factors for response to treatment of breast cancer and other solid tumors	2004 - 2008	PhD Tanja Čufer	3,618

We were not given permission by the researcher to publish data.